Skip to main content

Month: September 2022

VSBLTY CLOSES SECOND TRANCHE OF NON-BROKERED PRIVATE PLACEMENT FOR GROSS PROCEEDS OF APPROXIMATELY $2,466,550 AND ANNOUNCES DEBT SETTLEMENT

NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES Philadelphia, PA, Sept. 01, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (the “Company” or “VSBLTY”) (CSE: VSBY) announces that further to its news releases dated July 26 and 28, 2022, it has closed the second tranche (the “Second Tranche”) of its previously announced non-brokered private placement (the “Private Placement”) of units (the “Units”). Units were previously sold in a first tranche of the Private Placement concurrently with and on the same terms as the Units issued and sold under the previously announced best efforts marketed public offering which closed on July 28, 2022 (the “Public Offering”). The Units were offered and sold under the Public Offering by way of a short form prospectus filed in the provinces of British Columbia,...

Continue reading

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Bagsværd, Denmark and Watertown, Mass, US, 01 September 2022 – Novo Nordisk and Forma Therapeutics, Holdings Inc. (Nasdaq: FMTX) today announced that they have entered into a definitive agreement under which Novo Nordisk will acquire Forma Therapeutics for USD 20 per share in cash, which represents a total equity value of USD 1.1bn. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood disorders. The acquisition of Forma Therapeutics, including its lead development candidate, etavopivat, is aligned with Novo Nordisk’s strategy to complement and accelerate its scientific presence and pipeline in haemoglobinopathies, a group of disorders in which there is abnormal production or structure of the haemoglobin protein in the red blood cells. “Novo...

Continue reading

Solid Power to Present at Cowen 15th Annual Global Transportation & Sustainable Mobility Conference

LOUISVILLE, Colo., Sept. 01, 2022 (GLOBE NEWSWIRE) — Solid Power, Inc. (“Solid Power”) (Nasdaq: SLDP), an industry-leading developer of all-solid-state battery cells for electric vehicles, today announced its participation in the upcoming Cowen 15th Annual Global Transportation & Sustainable Mobility Conference to be held September 7-9, 2022. Doug Campbell, Chief Executive Officer, will be presenting. Mr. Campbell and Kevin Paprzycki, Chief Financial Officer, will participate in small group meetings as part of the conference. Solid Power’s presentation at the Cowen 15th Annual Global Transportation & Sustainable Mobility Conference is scheduled for 10:40 a.m. – 11:10 a.m. ET on Friday, September 9, 2022. A live webcast link of the presentation can be accessed via the link provided below or by visiting the Events &...

Continue reading

Magnite Helps Travel Texas Expand Cross-Platform Audience Reach With Programmatic Addressable Offering

Campaign achieved 21-35% incremental reach across key audience segments with the addition of linear addressable and higher conversion efficiency for linear addressable compared to OTT NEW YORK, Sept. 01, 2022 (GLOBE NEWSWIRE) — Magnite (NASDAQ: MGNI), the world’s largest independent omnichannel sell-side advertising platform, today announced that its programmatic addressable offering enabled Travel Texas to broaden their campaign footprint across key audience segments compared to OTT alone, driving overall incremental reach and growing their consumer pool by 21-35%. The results, measured in a cross-platform analysis by InnovidXP, also demonstrated a significantly higher conversion efficiency for linear addressable across Travel Texas’ key audience segments compared to CTV/OTT. “Working with Magnite has allowed us to reach our desired...

Continue reading

Correction to the XHTML file required by ESEF reporting standard regarding Innofactor Plc’s Financial Statement published on March 10, 2022

Innofactor Plc Annual Financial Report, on September 1, 2022, at 14:55 Finnish time On March 10, 2022, Innofactor published its Financial Statement in accordance with European Single Electronic Format (ESEF) reporting requirements with the format of the report being Extensible Hypertext Markup Language (XHTML). The notes to the Financial Statement, the parent company’s Financial Statement and the Report of the Board of Directors, which were not included in the original file, have now been added with XBRL tags. The updated XHTML file is available on www.innofactor.com/invest-in-us/releases-publications-and-reports/#annual-reports. Espoo, September 1, 2022 INNOFACTOR PLC Sami Ensio, CEO Additional information:Sami Ensio, CEOInnofactor PlcTel. +358 50 584 2029sami.ensio@innofactor.com Distribution:NASDAQ HelsinkiMain mediawww.innofactor.com Innofactor Innofactor...

Continue reading

TELUS completes C$2.3 billion acquisition of LifeWorks setting a new course for employer-focused healthcare

Successful acquisition expands the global footprint of TELUS Health, now covering corporate clients in more than 160 countries and 50 million lives worldwide VANCOUVER, British Columbia and TORONTO, Sept. 01, 2022 (GLOBE NEWSWIRE) — TELUS Corporation (“TELUS”) (TSX: T; NYSE: TU) today announced the completion of the previously disclosed acquisition by way of a plan of arrangement (the “Transaction”) of LifeWorks Inc. (“LifeWorks”) (TSX: LWRK), a world leader in providing digital and in-person solutions that support the total wellbeing of individuals – mental, physical, financial and social, solidifying TELUS Health as one of the largest companies providing digital-first health and wellness services and solutions that empower individuals to live their healthiest lives. TELUS Health is now positioned...

Continue reading

Sernova Receives Second Tranche Equity Investment from Evotec of $6.8 Million at a Price of $2.50 Per Share

LONDON, Ontario, Sept. 01, 2022 (GLOBE NEWSWIRE) — Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/ XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that it has completed the second and final tranche of its previously announced private placement with Evotec SE (FSE:EVT) (NASDAQ: EVO) of 2,709,800 common shares of the Company (“Common Shares”) at a price of $2.50 per share for total proceeds of $6,774,500. Upon completion of the second tranche, Evotec’s strategic investment in Sernova totals $27,098,000. “Evotec’s investment at $2.50 per share, significantly more than double yesterday’s closing price, reflects the value our strategic partner places on Sernova relative to the current trading price on the TSX,” commented Dr. Philip Toleikis, President and CEO of Sernova Corp. “The...

Continue reading

VSBLTY FORGES ALLIANCE WITH THE AL JABR GROUP TO BRING COMPUTER VISION & AI SECURITY SOLUTIONS TO THE MIDDLE EAST

PARTIES SIGN LOI AND COMMIT TO JOINT VENTURE CONTRACT WITHIN 60 DAYS Philadelphia PA, Sept. 01, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, today announced it has formed an alliance with the Al Jabr Group to bring digital out-of-home solutions and the Store as a Medium (SaaM) concept to retail outlets, the oil & gas industry and smart cities in five middle east countries. A family-owned multi-dimensional company with more than 6,000 employees in the region, Al Jabr already has invested USD$1.6 million in VSBLTY to date. The agreement calls for VSBLTY to provide advanced artificial intelligence (AI) technology for all deployments, while Al Jabr will be responsible for developing contracts...

Continue reading

Brady Corporation Reports Record EPS in its Fiscal 2022 Fourth Quarter and Announces its Fiscal 2023 EPS Guidance

Sales for the quarter increased 5.8 percent. Organic sales increased 9.0 percent. Gross profit margin increased to 50.4 percent in the fourth quarter of F’22 compared to 48.2 percent in the fourth quarter of F’21. Diluted EPS increased 52.8 percent to an all-time high of $0.81 in the fourth quarter of fiscal 2022 compared to $0.53 in the same quarter of the prior year. Diluted EPS Excluding Certain Items* increased 16.0 percent to an all-time record high of $0.87 in the fourth quarter of fiscal 2022 compared to $0.75 in the same quarter of the prior year. During the quarter and year ended July 31, 2022, we returned $35.5 million and $155.2 million, respectively, to our shareholders in the form of dividends and share repurchases. Diluted EPS guidance for the year ending July 31, 2023 was announced at a range of $3.13 to $3.43 on a GAAP...

Continue reading

Nano Dimension’s Q2/2022 Revenues: $11.1 Million, 1,268% Increase over Q2/2021

H1/2022 Revenue was $21.5 million, 1,227% increase over H1/2021 Conference call to be held today at 9:00 a.m. EDT WALTHAM, Mass., Sept. 01, 2022 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional metal & ceramic Additive Manufacturing (“AM”) 3D printers, today announced financial results for the second quarter ended June 30th, 2022.  Nano Dimension reported revenues of $11.1 million for the second quarter of 2022, an increase of 1,268% over the same quarter in 2021. Revenues for the six months period ended June 30th, 2022, were $21.5 million, which represent a 1,227% increase over the six months period ended June 30th, 2021. Revenues for Q2/2022 were 6% over Q1/2022.  The Company ended the quarter...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.